Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Psychiatry Res ; 188(3): 366-71, 2011 Aug 15.
Article in English | MEDLINE | ID: mdl-21269711

ABSTRACT

Memantine, a selective antagonist of the N-methyl-D-aspartate receptor, is approved for the treatment of moderate to severe Alzheimer's disease. Ion dysregulation is thought to be involved in the pathophysiology of bipolar illness, suggesting that memantine may be effective in treating bipolar manic and/or depressive episodes. We utilized two preclinical models of mania that mimic pathophysiologic changes seen in bipolar illness to examine the potential efficacy of memantine in the treatment of this disorder. Locomotor hyperactivity of male Sprague-Dawley rats in an open field was induced with intracerebroventricular (ICV) administration of 10(-3) M ouabain. Memantine (2.5, 5 or 7.5mg/kg), lithium (6.75 mEq/kg), or vehicle were administered acutely via intraperitoneal injection immediately prior to ouabain, then chronically for 7 days (oral memantine 20, 30, and 40 mg/kg/day in water; lithium 2.4 g/kg food). In a second model of bipolar disorder, cycling between population spikes and epileptiform bursts was investigated in rat hippocampal slices treated with ouabain (3.3 µM) alone or in combination with memantine (0.5, 1.0, and 5.0 µM). Ouabain-induced hyperlocomotion was normalized with acute and chronic lithium and chronic use of memantine. Memantine delayed the onset of ouabain-induced-cycling in hippocampal slices. Memantine may have antimanic properties.


Subject(s)
Bipolar Disorder/drug therapy , Excitatory Amino Acid Antagonists/therapeutic use , Memantine/therapeutic use , Action Potentials/drug effects , Animals , Antimanic Agents/pharmacology , Antimanic Agents/therapeutic use , Bipolar Disorder/physiopathology , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Exploratory Behavior/drug effects , Hippocampus/drug effects , In Vitro Techniques , Lithium Chloride/pharmacology , Lithium Chloride/therapeutic use , Male , Memantine/pharmacology , Ouabain/pharmacology , Rats , Rats, Sprague-Dawley , Statistics, Nonparametric , Time Factors
2.
Neurosci Biobehav Rev ; 31(6): 874-81, 2007.
Article in English | MEDLINE | ID: mdl-17720496

ABSTRACT

Psychiatric diseases in general, and bipolar illness in particular, are difficult to model in animals since the subjective nature of the core symptoms appears to preclude objective observation of behavioral changes. An adequate animal model of a psychiatric condition must fulfill three core criteria: share pathophysiological characteristics of the human condition (face validity), have similar behavioral manifestations as the human disease (construct validity), and improve with medications that improve the symptoms seen in afflicted humans (predictive validity). The ouabain model for bipolar illness mimics a widely reproduced biologic abnormality in mania: reduced sodium pump activity. An intracerebroventricular (ICV) administration of 5microL 10(-3)M ouabain induces motoric hyperactivity preventable by lithium, carbamazepine, and haloperidol. ICV ouabain may also produce environmentally dependent hypoactivity. The model, however, has not yet been examined for other potential manic behavior in rats such as reduced need for sleep, increased sexual activity, or increased irritability. While additional characterization of the model is required, the ouabain model for bipolar illness is the only available animal model that fulfills the three criteria for an adequate animal model for bipolar illness.


Subject(s)
Bipolar Disorder/enzymology , Enzyme Inhibitors/administration & dosage , Hyperkinesis/chemically induced , Ouabain/administration & dosage , Sodium-Potassium-Exchanging ATPase/drug effects , Animals , Bipolar Disorder/physiopathology , Cardenolides/administration & dosage , Disease Models, Animal , Humans , Hyperkinesis/enzymology , Injections, Intraventricular , Ion Transport/drug effects , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...